Wang, Wenjie
Liu, Luyao
Hui, Xiaoying
Wang, Ying
Ying, Wenjing
Zhou, Qinhua
Hou, Jia
Yang, Mi
Sun, Bijun
Sun, Jinqiao
Wang, Xiaochuan
Article History
Received: 15 January 2021
Accepted: 2 March 2021
First Online: 17 March 2021
Declarations
:
: The study was carried out at Children’s hospital of Fudan University (Shanghai, China). The protocol 2020–453 was approved by the Ethics Committee of the Children’s Hospital of Fudan University. Because the patient was under the age of 18 years, her parents gave written informed consent to participate tocilizumab therapy and report data in accordance with the declaration of Helsinki.
: Written informed consent for publication of identifying images and other personal or clinical details was obtained from the patient’s parents.
: The authors declare that they have no competing interests.